WoodTrust Financial Corp Purchases 1,350 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)

WoodTrust Financial Corp lifted its position in shares of iRhythm Technologies, Inc. (NASDAQ:IRTCFree Report) by 10.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,732 shares of the company’s stock after purchasing an additional 1,350 shares during the quarter. WoodTrust Financial Corp’s holdings in iRhythm Technologies were worth $1,470,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Quent Capital LLC bought a new stake in shares of iRhythm Technologies during the fourth quarter valued at approximately $161,000. SeaCrest Wealth Management LLC bought a new stake in iRhythm Technologies in the fourth quarter worth $205,000. Diversified Trust Co bought a new stake in iRhythm Technologies in the fourth quarter worth $212,000. Exchange Traded Concepts LLC boosted its holdings in iRhythm Technologies by 3.5% in the fourth quarter. Exchange Traded Concepts LLC now owns 218,415 shares of the company’s stock worth $23,379,000 after acquiring an additional 7,428 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in iRhythm Technologies by 0.9% in the third quarter. Vanguard Group Inc. now owns 2,957,749 shares of the company’s stock worth $278,797,000 after acquiring an additional 26,469 shares in the last quarter.

Wall Street Analysts Forecast Growth

IRTC has been the topic of several analyst reports. Canaccord Genuity Group boosted their target price on iRhythm Technologies from $121.00 to $133.00 and gave the stock a “buy” rating in a report on Friday, February 23rd. Needham & Company LLC boosted their target price on iRhythm Technologies from $136.00 to $137.00 and gave the stock a “buy” rating in a report on Friday, February 23rd. Truist Financial boosted their target price on iRhythm Technologies from $115.00 to $133.00 and gave the stock a “buy” rating in a report on Friday, December 22nd. JPMorgan Chase & Co. decreased their price target on iRhythm Technologies from $142.00 to $133.00 and set an “overweight” rating for the company in a research note on Friday, February 23rd. Finally, Citigroup upgraded iRhythm Technologies from a “neutral” rating to a “buy” rating and set a $110.00 price target for the company in a research note on Monday, December 11th. One investment analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, iRhythm Technologies has an average rating of “Moderate Buy” and an average price target of $135.11.

Read Our Latest Stock Analysis on iRhythm Technologies

iRhythm Technologies Stock Performance

iRhythm Technologies stock traded down $0.75 during mid-day trading on Wednesday, reaching $108.50. 427,871 shares of the stock traded hands, compared to its average volume of 431,139. The stock has a market capitalization of $3.36 billion, a PE ratio of -26.89 and a beta of 1.30. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.15 and a quick ratio of 2.02. iRhythm Technologies, Inc. has a 12-month low of $70.24 and a 12-month high of $140.23. The business’s 50-day moving average is $113.52 and its 200-day moving average is $99.40.

iRhythm Technologies (NASDAQ:IRTCGet Free Report) last posted its quarterly earnings data on Thursday, February 22nd. The company reported ($1.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.66). The firm had revenue of $132.51 million for the quarter, compared to analysts’ expectations of $131.14 million. iRhythm Technologies had a negative net margin of 25.05% and a negative return on equity of 56.38%. As a group, sell-side analysts predict that iRhythm Technologies, Inc. will post -3.14 EPS for the current fiscal year.

Insiders Place Their Bets

In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,261 shares of the company’s stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $121.96, for a total value of $153,791.56. Following the completion of the sale, the executive vice president now owns 32,967 shares in the company, valued at $4,020,655.32. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CEO Quentin S. Blackford sold 24,701 shares of the company’s stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $121.96, for a total value of $3,012,533.96. Following the completion of the transaction, the chief executive officer now owns 180,015 shares of the company’s stock, valued at $21,954,629.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Daniel G. Wilson sold 1,261 shares of the company’s stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $121.96, for a total value of $153,791.56. Following the completion of the transaction, the executive vice president now directly owns 32,967 shares of the company’s stock, valued at approximately $4,020,655.32. The disclosure for this sale can be found here. Insiders sold a total of 35,052 shares of company stock worth $4,274,942 over the last quarter. 0.43% of the stock is currently owned by corporate insiders.

iRhythm Technologies Company Profile

(Free Report)

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

Further Reading

Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTCFree Report).

Institutional Ownership by Quarter for iRhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.